Abrdn World Healthcare Fund (THW)

The immediate outlook is sharply negative due to a relentless selling pressure over the last two weeks, with the price dropping from $13.90 to $12.28, signaling a clear short-term bearish trend. While the valuation appears cheap at a P/E of roughly 5.8, the market is pricing in significant distress, evidenced by the asset trading well below its 52-week high and struggling to hold above its 200-day moving average. The long-term picture is mixed; although the business has shown resilience with four positive years out of nine, the trailing decade has been a net decline of nearly 13%, and the most recent annual performance was negative, suggesting the market views the current fundamentals as insufficient to reverse the downtrend. On the income side, the fund offers a substantial yield of nearly 12%, but this comes with a warning flag: the payout ratio sits at 66%, indicating that the majority of earnings are being distributed rather than reinvested, which may limit capital appreciation potential and suggests the yield is partly a function of falling share prices.